CAS 1009298-09-2

5-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol

Description:

5-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol, with CAS number 1009298-09-2, is a complex organic compound characterized by its multi-ring structure, which includes a pyrido-pyrimidine core and a methoxy-substituted benzene moiety. This compound features a morpholine group, contributing to its potential biological activity, particularly in medicinal chemistry. The presence of multiple functional groups suggests that it may exhibit diverse chemical reactivity and solubility properties. Its stereochemistry, indicated by the (3S) configuration, implies specific spatial arrangements that could influence its interaction with biological targets. The compound's potential applications may include roles as a pharmaceutical agent, given its structural features that are often associated with bioactive molecules. However, detailed studies on its pharmacokinetics, toxicity, and efficacy would be necessary to fully understand its characteristics and potential uses in therapeutic contexts.

Formula: C₂₅H₃₁N₅O₄

InChI: InChI=1S/C25H31N5O4/c1-16-14-33-10-8-29(16)24-20-5-6-21(18-4-7-22(32-3)19(12-18)13-31)26-23(20)27-25(28-24)30-9-11-34-15-17(30)2/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17-/m0/s1

InChI key: InChIKey=KVLFRAWTRWDEDF-IRXDYDNUSA-N

SMILES: C[C@@H]1N(C=2C3=C(N=C(N2)N4[C@@H](C)COCC4)N=C(C=C3)C5=CC(CO)=C(OC)C=C5)CCOC1

Synonyms:

• 5-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol
• Azd 8055
• Azd8055
• Benzenemethanol, 5-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-
• Ccg 168
• Lm1148
• Nvp-Ccg 168
• [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
• [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-2-methoxyphenyl]methanol
• [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol AZD 8055
• AZD 8055 [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
• (5-{2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl}-2-methoxyphenyl)methanol
• AZD8055,AZD-8055
• AZD8055, >=98%
• {5-[2,4-Bis-(3-methyl-morpholin-4-yl)-pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-phenyl}-methanol
• AZD-8055 USP/EP/BP
• [5-[2,4-Bis((3S)-3-MethylMorpholin-4-yl)pyrido[
• (5-{2,4-dichloropyrido[2,3-d]pyriMidin-7-yl}-2-Methoxyphenyl)Methyl 2,2-diMethylpropanoate
• AZD-8055; AZD8055; AZD 8055.
• Propanoic acid, 2,2-dimethyl-, [5-(2,4-dichloropyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl]methyl ester
• CS-1935

Benzenemethanol, 5-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-

CAS: 1009298-09-2

Formula: C₂₅H₃₁N₅O₄

Purity: 96%

Color and Shape: Solid

Molecular weight: 465.5447

Ref: IN-DA000383

AZD-8055

CAS: 1009298-09-2

AZD-8055

Purity: ≥95%

Molecular weight: 465.54g/mol

Ref: 54-BUP13178

Azd-8055

CAS: 1009298-09-2

Azd-8055

Purity: 97%

Molecular weight: 465.54g/mol

Ref: 54-OR1024083

AZD-8055

CAS: 1009298-09-2

AZD8055 is an ATP-competitive mTOR inhibitor (IC50: 0.8 nM in MDA-MB-468 cells). It is ~1,000-fold selective for mTOR over all PI3K isoforms.

Formula: C₂₅H₃₁N₅O₄

Purity: 98% - 99.69%

Color and Shape: Solid

Molecular weight: 465.54

Ref: TM-T1859

AZD-8055

CAS: 1009298-09-2

Purity: ≥ 95.0%

Color and Shape: Yellow powder or solid

Ref: 7W-GW4102

AZD8055

Controlled Product

CAS: 1009298-09-2

Applications A potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM. It inhibits the phosphorylation of mTORC1 substrates p70S6K and 4E-BP1 as well as phosphorylation of the mTORC2 substrate AKT and downstream proteins. The rapamycin-resistant T37/46 phosphorylation sites on 4E-BP1 were fully inhibited by AZD8055, resulting in significant inhibition of cap-dependent translation. In vitro, AZD8055 potently inhibits proliferation and induces autophagy in H838 and A549 cells. In vivo, AZD8055 induces a dose-dependent pharmacodynamic effect on phosphorylated S6 and phosphorylated AKT at plasma concentrations leading to tumor growth inhibition. Dual mTORC1/C2 inhibitor
References Chresta, C.M. et al.: Cancer Res., 70, 288 (2010); Sini, P. et al. Autophagy., 6 (2010); Marshall, G. et al.: Biochem. Soc. Trans., 39, 456 (2011);

Formula: C₂₅H₃₁N₅O₄

Color and Shape: Neat

Molecular weight: 465.54

Ref: TR-A808130

AZD 8055

CAS: 1009298-09-2

A selective and ATP-competitive inhibitor of mTOR kinase with an IC50 value of 0.8 nM. Inhibits growth of a range of tumor types in vivo and in vitro. Effective in preventing and treating endocrine-resistant breast cancer. Causes autophagy in H838 and A549 cells.

Formula: C₂₅H₃₁N₅O₄

Purity: Min. 95%

Molecular weight: 465.54 g/mol

Ref: 3D-FA18068